Assay Genie New Asian Distributor May 2024
Dublin, Ireland — May 20th 2024 — Assay Genie, a leading supplier of ELISA Kits, Antibodies, Cellular Assays, and In Vivo Monoclonal Antibodies, is pleased to announce partnerships with three new distributors across the Middle East and Asia. The newly appointed distributors are AFMS in Saudi Arabia, Biotechno Labs in India, and Lab-A-Porter in Hong Kong and Macau.
These strategic partnerships mark a significant milestone in Assay Genie's ambitious growth plan, aiming to become one of the foremost suppliers in the biotechnology industry. With the addition of these new partners, Assay Genie now has distribution agreements in 10 countries across Asia and a total of 66 countries worldwide.
"We are thrilled to welcome AFMS, Biotechno Labs, and Lab-A-Porter to the Assay Genie family," said Dr. Colm Ryan, CEO at Assay Genie. "These partnerships will enhance our ability to serve customers in these key regions, providing them with access to our high-quality products and exceptional customer service. This expansion reflects our commitment to meeting the growing demand for reliable and innovative biotech solutions globally."
AFMS, Biotechno Labs, and Lab-A-Porter are well-respected distributors in their respective regions, known for their dedication to excellence and customer satisfaction. By leveraging their local expertise and established networks, Assay Genie aims to strengthen its market presence and deliver cutting-edge products to researchers and scientists across Saudi Arabia, India, Hong Kong, and Macau.
Assay Genie's comprehensive product portfolio includes a wide range of ELISA Kits, Antibodies, Cellular Assays, and In Vivo Monoclonal Antibodies, designed to support advancements in scientific research and development. With these new partnerships, Assay Genie is better positioned to provide innovative solutions that meet the evolving needs of the scientific community.
For more information about Assay Genie and its products, please contact info@assaygenie.com
Recent Posts
-
IgG1 Plasma Cells: The Emerging Biomarker for Predicting Cancer Immunotherapy Success
In the relentless fight against cancer, immunotherapy has emerged as a beacon of hope, harnessing t …24th Feb 2026 -
The Rise of Cancer Neuroscience: How Neural Circuits Drive Tumor Progression
For decades, we viewed cancer as a rogue army of cells, a biological glitch driven solely by geneti …23rd Feb 2026 -
CRISPR-Powered Light Sensors: A New Frontier in Ultra-Sensitive Cancer Detection
Cancer detection often relies on advanced imaging or invasive procedures, frequently catching the d …20th Feb 2026